Untargeted Plasma Metabolomics Reveals Molecular Subtypes Associated with Reintervention Risk in Peripheral Artery Disease after Revascularization
Journal of Proteome Research · 06.11.2026 · 25 (11) · 6126-6138
DOI: 10.1021/acs.jproteome.6c00439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 26.10.2026. Verfasst von Bowen Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laborat…. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Metabolomics, Metabolome. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China (NSFC), National High Level Hospital Clinical Research Funding Project.
Abstract (Originalsprache)
Peripheral artery disease (PAD) shows substantial outcome heterogeneity after revascularization that is incompletely explained by conventional severity indicators. We performed untargeted plasma LC–MS metabolomics in 175 PAD patients undergoing revascularization and applied variability-based feature selection, unsupervised clustering, pathway and chemical-class analyses, survival modeling, and metabolite prioritization. Three metabolically defined molecular subtypes were identified: redox protective (n = 93), metabolic burden (n = 72), and renal dysfunction (n = 10). Compared to the redox-protective subtype, the metabolic-burden subtype showed higher risks of composite adverse outcomes, reintervention, and major adverse cardiovascular events, accompanied by acylcarnitine accumulation, fatty-acyl enrichment, and COX-prostaglandin-related inflammatory signaling. Secondary clustering of high-risk patients identified a subgroup with increased reintervention risk, despite no corresponding increase in Rutherford classification or ankle-brachial index severity, characterized by sphingomyelin, diglyceride, and thromboxane/leukotriene-related lipid mediator signatures. A five-metabolite score was associated with reintervention risk and showed numerically higher apparent discrimination than the original and expanded clinical models. These findings establish an untargeted metabolomics framework for molecular subtyping of PAD after revascularization and nominate metabolic phenotypes for future validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Aca…
- Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing100730, P. R. China.
- Medical School, University of Chinese Academy of Sciences, Beijing101408, P. R. China.
ORCID-Profile: Bowen Zhang, Yifan Cao
Förderung
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China (NSFC)
- National High Level Hospital Clinical Research Funding Project
- Beijing Municipal Natural Science Foundation
Zitieren
APA
Zhang, B., Cao, Y., Zhao, W., Luo, J., Li, X., Zhang, X., Xu, Z., Wang, J., Chen, Z., Chen, L., Diao, Y., & Li, Y. (2026). Untargeted Plasma Metabolomics Reveals Molecular Subtypes Associated with Reintervention Risk in Peripheral Artery Disease after Revascularization. Journal of Proteome Research, 25(11), 6126-6138. https://doi.org/10.1021/acs.jproteome.6c00439
Vancouver
Zhang B, Cao Y, Zhao W, Luo J, Li X, Zhang X, et al. Untargeted Plasma Metabolomics Reveals Molecular Subtypes Associated with Reintervention Risk in Peripheral Artery Disease after Revascularization. Journal of Proteome Research. 2026;25(11):6126-6138. doi:10.1021/acs.jproteome.6c00439
BibTeX
@article{Zhang2026,
author = {Zhang, Bowen and Cao, Yifan and Zhao, Wenxin and Luo, Jiayin and Li, Xiaolu and Zhang, Xihao and Xu, Zhengxi and Wang, Jiyang and Chen, Zuoguan and Chen, Lidan and Diao, Yongpeng and Li, Yongjun},
title = {Untargeted Plasma Metabolomics Reveals Molecular Subtypes Associated with Reintervention Risk in Peripheral Artery Disease after Revascularization},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {11},
pages = {6126--6138},
doi = {10.1021/acs.jproteome.6c00439}
}
EUVIMED